Sponsored Content

PharmaLinea’s iron supplement delivers improvements in hemoglobin comparable to ferrous sulfate with fewer side effects

PharmaLinea, a Slovenian developer and manufacturer of private label food supplements, has announced the completion of a clinical study evaluating its finished formulation for iron deficiency.

The randomized, double-blind trial assessed the efficacy and safety of the company’s >Your< Iron Forte Capsules and a low-dose ferrous sulfate comparator (ferrous sulfate capsules). Results showed that >Your< Iron Forte Capsules delivered comparable improvements in hemoglobin and iron status, while demonstrating a more favorable tolerability profile with significantly fewer side effects, thus addressing a key limitation of conventional iron supplements.

The 12-week study included 101 adults with mild to moderate, non-anemic dietary iron deficiency who followed a once-daily supplementation regimen. Researchers monitored hematological and iron-related parameters as well as adverse events, with the primary endpoint being the change in hemoglobin from baseline.

“This is already the third study confirming the efficacy of the finished products in >Your< Iron Line, which has also received several industry awards,” commented PharmaLinea’s Marketing Director, Matevž Ambrožič.

Iron deficiency is the most common nutritional deficiency globally, affecting particularly women of reproductive age and children. If left unaddressed, it can progress to iron deficiency anemia. The World Health Organization (WHO) estimates that 40% of children aged 6–59 months, 37% of pregnant women, and 30% of women aged 15–49 years globally are anemic. WHO guidelines to reduce the prevalence of anemia emphasize improving dietary diversity, infant feeding practices, and increasing micronutrient intake, including iron supplementation.

However, poor gastrointestinal tolerability remains a key challenge of conventional iron supplements and a frequent cause of low compliance. Addressing this limitation is critical to improving real-world outcomes in iron deficiency management.

In response, PharmaLinea developed >Your< Iron Line, which has become the company’s leading iron supplement line. With clinically supported efficacy and award-winning taste, >Your< Iron Line products have been successfully launched in over 30 markets worldwide.

The collection of assets on >Your< Iron Line is unmatched. Alongside the newly completed study, which is pending publication, it includes multiple clinical evaluations and industry recognitions, such as:

• gold-standard clinical trial on iron-deficient children with >Your< Iron Syrup
• an animal model study comparing >Your< Iron Syrup to ferrous sulfate
• NutraIngredients-Asia Award for >Your< Iron Syrup
• Forbes Best Brand Award for our client’s launch of >Your< Iron Line
• Runner-up Taste Award for >Your< Iron Forte Liquid at Vitafoods Asia
• Best-Tasting Functional Beverage Award for >Your< Iron Syrup at Vitafoods Europe
• Best-Tasting Functional Beverage Award for >Your< Iron Forte Liquid Sticks at Vitafoods Europe
• Annual Popular Product Flavor Award for >Your< Iron Syrup at Functional Foods for Wellness Summit
• Annual Product Form Innovation Award for >Your< Iron Forte Liquid Sticks at Functional Foods for Wellness Summit